M, K., IC, S., SY, A., HC, J., JS, K., CH, L., . . . JS, A. (2025). Cytogenetic risk-associated outcomes of antithymocyte globulin use in HLA-matched sibling transplantation for acute myeloid leukemia. Annals of hematology, 104(11), 5995. https://doi.org/10.1007/s00277-025-06608-3
Chicago Style (17th ed.) CitationM, Kim, Song IC, Ahn SY, Jang HC, Koh JS, Lee CH, Kim HJ, Yhim HY, and Ahn JS. "Cytogenetic Risk-associated Outcomes of Antithymocyte Globulin Use in HLA-matched Sibling Transplantation for Acute Myeloid Leukemia." Annals of Hematology 104, no. 11 (2025): 5995. https://doi.org/10.1007/s00277-025-06608-3.
MLA (9th ed.) CitationM, Kim, et al. "Cytogenetic Risk-associated Outcomes of Antithymocyte Globulin Use in HLA-matched Sibling Transplantation for Acute Myeloid Leukemia." Annals of Hematology, vol. 104, no. 11, 2025, p. 5995, https://doi.org/10.1007/s00277-025-06608-3.